Fewer Treatments for Prostate Cancer
3/4/2020
WILKES-BARRE, PA (March, 2020) - Commonwealth Health Cancer Center at Wilkes-Barre General Hospital offers stereotactic body radiotherapy (SBRT) for patients with low- and intermediate-risk prostate cancer. This noninvasive method delivers the entire course of treatment in just 5 sessions. Each painless treatment session takes about 20 minutes and is monitored with image guidance.
“For patients who meet the medical criteria; SBRT may reduce treatment from 25 to 45 sessions down to just 5”, said David Horvick, M.D., medical director of the Cancer Center at Wilkes-Barre General Hospital, located at 575 N. River Street. “I have been treating other types of cancer with SBRT for 20 years. Recent studies support the safety and efficacy of SBRT for selected patients with prostate cancer”, added Dr. Horvick.
SBRT achieves the same cure rates as other prostate cancer therapies; but is more convenient than conventional intensity modulated radiation therapy (IMRT) and is less invasive than radiation implants (brachytherapy) or surgery.
The linear accelerator equipment at the Cancer Center at Wilkes-Barre General Hospital is ideally constructed for the precision needed to deliver the high dose treatments required by SBRT, resulting in fewer sessions.
Call (570) 552-1300 for more information or to refer a patient.
David Horvick, M.D., is employed by Commonwealth Health Physician Network and is the medical director of the Cancer Center at Wilkes-Barre General Hospital. He is a graduate of Thomas Jefferson Medical College and is American Board certified in Radiation Oncology. Dr. Horvick treats many types of malignancies, including prostate, breast, lung, brain, head, neck and gastrointestinal.
Back